OPTIVAR is indicated for the treatment of itching associated with allergic conjunctivitis in patients as young as 3 years of age.
In controlled clinical studies, some patients experienced brief eye burning/stinging, headache, and bitter taste. Less than 1% of patients stopped using OPTIVAR because of these effects. OPTIVAR should not be used if you are sensitive to any of the medication's components.
OPTIVAR® is distributed by Meda Pharmaceuticals Inc.|
Copyright © 2008-2014 Meda Pharmaceuticals Inc. All rights reserved.
OPT6035 February 2007